Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer

Oncogene

Volumn 24, Issue 41, 2005, Pages 6323-6327

  Fukui, Takayuki ^a   Kondo, Masashi ^a   Ito, Genshi ^a   Maeda, Osamu ^a   Sato, Naohito ^a   Yoshioka, Hiromu ^a   Yokoi, Kohei ^a   Ueda, Yuichi ^a   Shimokata, Kaoru ^a   Sekido, Yoshitaka ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chromosome 8p; Hypermethylation; Non small cell lung cancer; SFRP1; Tumor suppressor gene

Indexed keywords

PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC CODE; HETEROZYGOSITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; GENE SILENCING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 30544447981     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208777     Document Type: Article

References (30)

1. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM and Morton DG. (2004). Cancer Res., 64, 883-888.
2. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M and Nakamura Y. (1992). Cancer Res., 52, 5368-5372.
3. Giles RH, van Es JH and Clevers H. (2003). Biochim. Biophys. Acta, 1653, 1-24.
4. Girard L, Zöchbauer-Müller S, Virmani AK, Gazdar AF and Minna JD. (2000). Cancer Res., 60, 4894-4906.
5. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y and Nakamura Y. (1992). Cancer Res., 52, 6696-6698.
6. Howe LR and Brown AM. (2004). Cancer Biol. Ther., 3, 36-41.
7. Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O, Kawabe T, Hasegawa Y, Shimokata K and Sekido Y. (2004). Cancer Res., 64, 3838-3843.
8. Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, Yoshioka H, Ueda Y, Shimokata K and Sekido Y. (2005). Cancer Lett., 225, 131-139.
9. Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, Stohr R, Simon R, Sauter G, Leibiger H, Essers L, Weber B, Hermann K, Rosenthal A, Hartmann A and Dahl E. (2004). Int. J. Oncol., 25, 641-649.
10. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F and Jablons DM. (2004). Oncogene, 23, 6672-6676.
11. Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K and Sekido Y. (2004). Oncogene, 23, 964-972.
12. Minna JD, Fong K, Zöchbauer-Müller S and Gazdar AF. (2002). Cancer J., 8 (Suppl. 1), S41-S46.
13. Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K and Sekido Y. (2004). Cancer, 100, 1673-1682.
14. Morin PJ and Weeraratna AT. (2003). Cancer Treat. Res., 115, 169-187.
15. Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, Jen J and Testa JR. (2001). Genes Chromosomes Cancer, 31, 282-287.
16. Polakis P. (2000). Genes Dev., 14, 1837-1851.
17. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG and Sidransky D. (2002). Cancer Res., 62, 3659-3662.
18. Sekido Y, Fong KM and Minna JD. (2003). Annu. Rev. Med., 54, 73-87.
19. Sekido Y, Sato M, Usami N, Shigemitsu K, Mori S, Maeda O, Yokoi T, Hasegawa Y, Yoshioka H and Shimokata K. (2002). Cancer Genet. Cytogenet., 137, 33-42.
20. Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, Horio Y, Hasegawa Y, Bader SA, Gazdar AF, Minna JD, Hida T, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M and Shimokata K. (2001). Oncogene, 20, 4249-4257.
21. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C and Hartmann A. (2004). Lab. Invest., 84, 465-478.
22. Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R and Yokota J. (2001). Genes Chromosomes Cancer, 30, 316-321.
23. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB. (2002). Nat. Genet., 31, 141-149.
24. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Dong Chen W, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG and Baylin SB. (2004). Nat. Genet., 36, 417-422.
25. Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW, Miyamoto K, Yoshino O, Yasugi T, Taketani Y and Ushijima T. (2004). Cancer Sci., 95, 741-744.
26. Toyooka S, Fukuyama Y, Wistuba II, Tockman MS, Minna JD and Gazdar AF. (2002). Clin. Cancer Res., 8, 2292-2297.
27. Uchiyama M, Usami N, Kondo M, Mori S, Ito M, Ito G, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Minna JD, Shimokata K and Sekido Y. (2003). Int. J. Cancer, 107, 962-969.
28. Usami N, Sekido Y, Maeda O, Yamamoto K, Minna JD, Hasegawa Y, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M and Shimokata K. (2003). Oncogene, 22, 7923-7930.
29. Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B, Minna JD and Gazdar AF. (1999). Cancer Res., 59, 1973-1979.
30. Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC and Reynolds SH. (2004). Oncogene, 23, 1405-1411.